It’s once again that time of year when the mesothelioma community descends on Washington, D.C. for the 2010 International Symposium on Malignant Mesothelioma hosted by the Mesothelioma Applied Research Foundation

This year the 3-day meso conference will run from June 10-12, 2010. Day one will be spent visiting congressional leaders. Day two and three will feature presentations by leading researchers and doctors about the most recent developments for the treatment of meso. Support sessions will also be available for meso patients and their families throughout the event. Several representatives from Simmons will be attending to show our support.

A sampling of the presentations I’m looking forward to include:

  • Navigating Mesothelioma Clinical Trials with GPS (Getting Personalized Service)

Presented by Robert Taub, MD, PhD

  • Present and Future of Meso Treatment: Surgeon and Researcher Perspective 

Presented by Harvey Pass, MD

  • Update on Clinical Trials and Meso Research

Presented by Mary Hesdorffer, MS, APRN-BC, Meso Foundation Medical Liaison

Click here to view the full agenda.(PDF)

During this year’s conference, MARF will recognize three families whose selflessness has helped raise awareness about the dangers of asbestos exposure and mesothelioma.  According to MARF:

“The Bendix family, the Ruble family and the Sterling family have endured tremendous personal losses at the hand of mesothelioma. Despite knowing that their loved ones could not personally benefit from the results of their work, they banded together with friends and communities, to ensure hope for future generations, by funding three critical research projects through the Meso Foundation’s Research Program.”

It’s contributions families and individuals like this make that move us closer to the day when better treatment options become available and closer to finding a cure. I encourage all of you to join us as the mesothelioma community comes together to fight back against this orphan disease.

Click here to register for the 2010 International Symposium on Malignant Mesothelioma